Nefla M, Holzinger D, Berenbaum F, Jacques C. The danger from within: alarmins in arthritis. Nat Rev Rheumatol. 2016 Nov; 12(11):669-683. doi: 10.1038/nrrheum.2016.162. Review. PubMed PMID: 27733758
Walscheid K, Weinhage T, Foell D, Heinz C, Kasper M, Heiligenhaus A. Phenotypic changes of peripheral blood mononuclear cells upon corticosteroid treatment in idiopathic intermediate uveitis. Clinical Immunology. 2016 Oct 29. do: 10.1016/j.clim.2016.10.013
Geven EJ, van den Bosch MH, Di Ceglie I, Ascone G, Abdollahi-Roodsaz S, Sloetjes AW, Hermann S, Schäfers M, van de Loo FA, van der Kraan PM, Koenders MI, Foell D, Roth J, Vogl T, van Lent PL. S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis. Arthritis Res There. 2016 Oct 24;18(1):247. PMID: 27776554
Holzinger D, Roth J. Alarmin consequences - autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1. Curr Opin Rheumatol. 2016 Sept; 28(5):550-9. doi: 10.1097/BOR.0000000000000314
Lavric M, Miranda-Garcia MA, Holzinger D, Foell D, Wittkowski D. Alarmins firing arthritis: Helpful diagnostic tools and promising therapeutic targets. Joint Bone Spine. 2016 Sept 19. pii: S1297-319X(16)30127-0. doi: 10.1016/j.jbspin.2016.06.101. PubMed PMID: 27659403
Speth F, Haas JP, Hinze CH. Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases. Pediatric Rheumatol Online J. 2016 Sep 13;14(1):52. doi: 10.1186/s12969-016-0112-6
Leite D, Masemann D, Schied T, Bergmeier V, Vogl T, Loser K, Brachvogel B, Varga G, Ludwig S, Wixler V. Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes. J Pathol. 2016 Aug 24. doi: 10.1002/path.4786. PMID: 27555499
Däbritz J, Weinhage T, Varga G, Wirth T, Ehrchen JM, Barczyk-Kahlert K, Roth J, Schwarz T, Foell D. Activation-dependent cell death of human monocytes is a novel mechanism of fine-tuning inflammation and autoimmunity. Eur J Immunol. 2016 Aug; 46(8):1997-2007. doi: 10.1002/eji.201545802. PMID: 27159026
Wilsmann-Theis D, Wagenpfeil J, Holzinger D, Roth J, Koch S, Schnautz S, Bieber T, Wenzel J. Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity. J Eur Acad Dermatol Venerol. 2016 Jul. doi: 10.1111/jdv.13269
Cypers H, Varkas G, Beeckman S, Debusschere K, Vogl T, Roth J, Drennan MB, Lavric M, Foell D, Cuvelier CA, De Vos M, Delanghe J, Van den Bosch F, Elewaut D. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Ann Rheum Dis. 2016 Jul; 75(7): 1357-62. doi: 10.1136/annrheumdis-2015-208025
Gohar F, Kessel C, Lavric M, Holzinger D, Foell D. Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks? Arthritis Res Ther. 2016 Jul 13;18:163. doi: 10.1186/s13075-016-1069-z. PMID: 27411444 Gohar F,
Orak B, Kallinich T, Jeske M, Lieber M, von Bernuth H, Giese A, Weissbarth-Riedel E, Haas JP, Dressler F, Holzinger D, Lohse P, Neudorf U, Lainka E, Hinze C, Masjosthusmann K, Kessel C, Weinhage T, Foell D, Wittkowski H. Secretory Activity of Neutrophils Correlates With Genotype in Familial Mediterranean Fever. Arthritis Rheumatol. 2016 Jun 22. doi: 10.1002/art.39784. [Epub ahead of print] PMID: 27333294
Ward TM, Yuwen W, Voss J, Foell D, Gohar F, Ringold S. Sleep Fragmentation and Biomarkers in Juvenile Idiopathic Arthritis. Biol Res Nurs. 2016 May;18(3):299-306. doi: 10.1177/1099800415609997. PMID: 26512051
Perez-Witzke D, Miranda-Garcia MA, Suarez N, Becerra R, Duque K, Porras V, Fuenmayor J, Montano RF. A novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro sCD23 production and lymphocyte proliferation. Immunology. 2016 May; 148(1):40-55. doi: 10.1111/imm.12586. PubMed PMID:26801967
Lippitz K, Waldkirch J, Kessel C, Varga G, Foell D. Translationale Forschung in der pädiatrischen Rheumatologie. Z Rheumatol. 2016 Apr; 75(3):276-283. PMID: 26800663
Nair SC, Welsing PM, Choi IY, Roth J, Holzinger D, Bijlsma JW, van Laar JM, Gerlag DM, Lafeber FP, Tak PP. A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients. PLoS One. 2016 Mar 30;11(3):e0152362. doi: 10.1371/journal.pone.0152362. eCollection 2016. PMID: 27029006
Hinze C, Schiborr M, Beck L, Foell D, Holzinger D. Diagnosis of subclinical arthritis: comparing clinical examination, joint ultrasound, magnetic resonance imaging and biomarkers. Zeitschr Rheumat.2016 Mar; 75:S2-S2
Hadamitzky M, Bösche K, Wirth T, Buck B, Beetz O, Christians U, Schniedewind B, Lückemann L, Güntürkün O, Engler H, Schedlowski M. Memory-updating abrogates extinction of learned immunosuppression. Brain Behav Immun. 2016 Feb; 52:40-48. pii: S0889-1591(15)30017-9. doi: 10.1016/j.bbi.2015.09.009. PubMed PMID:2638632
van Dijkhuizen EH, Pouw JN, Scheuern A, Hügle B, Hardt S, Ganser G, Kümmerle-Deschner JB, Horneff G, Holzinger D, Bulatović Ćalasan M, Wulffraat NM. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study. Clin Exp Rheumatol. 2016 Jan-Feb;34(1):148-54.
Schwegmann K, Bettenworth D, Hermann S, Faust A, Poremba C, Foell D, Schäfers M, Domagk D, Lenz P. Detection of Early Murine Colorectal Cancer by MMP-2/-9-Guided Fluorescence Endoscopy. Inflamm Bowel Dis. 2016 Jan;22(1):82-91. doi: 10.1097/MIB.0000000000000605. PMID: 26457379
Brückner M, Lenz P, Mücke M, Gohar F, Willeke P, Domagk D and Bettenworth D. Diagnostic imaging advances in murine models of colitis. World J Gastroenterol. 2016 Jan 21;22(3):996–1007
Grom AA, Ilowite NT, Pascual V, Brunner HI, Martini A, Lovell D, Ruperto N, Pediatric International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group, Leon K, Lheritier K, Abrams K. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Canakinumab. Arthritis Rheumatol. 2016 Jan;68(1):218-28. doi:10.1002/art.39407